H-BIO – The regional High Technology District “Health and Biotechnology”

H-BIO – The regional High Technology District “Health and Biotechnology” 2018-08-29T08:18:40+00:00

Description

H-BIO is a high technology cluster, established as a Public/Private Consortium in September 2012, within the Framework Agreement between the Italian Ministry for Research and Higher Education (MIUR) and the Apulia Regional Government. H-BIO aims to develop the regional cluster in the strategic sector of Health and Biotechnology, by bringing together the critical mass of scientific expertise and industries operating in the region. Innovation in this sector has a critical role for the development of research at academic level, as well as for the transfer of research results to industry in order to make them available to patients who represent the ultimate end-users. Based on a careful analysis of the potential expressed by the university and research network in Apulia, together with the numerous initiatives already in place in this field and taking into account the needs and interest
expressed by the manufacturing sector, the Cluster’s activities are focused on 4 specific strategic areas: Personalised medicine; Advanced Therapy; Molecular and advanced diagnostics; New manufacturing processes. The main activities of the Cluster include: Research and Development Projects in the aforementioned strategic areas; Local initiatives, involving: support for technology transfer and enterprise development; Networking; Support on regulation and patenting. The H-BIO Apulia Cluster has 11 Public Partners and 25 Private Partners. H-BIO participates, directly or indirectly through its partners, in various national and international Networks.

Members

University of Bari “Aldo Moro”, Polytechnic of Bari, University of Salento, University of Foggia, Fondazione di Religione e di Culto " Casa Sollievo della Sofferenza" – Opera di San Pio da Pietrelcina, IRCCS Istituto Tumori " Giovanni Paolo II”, Ente Ospedaliero Specializzato In Gastroenterologia Saverio De Be, Consorzio CARSO – Centro di Addestramento e Ricerca Scientifica in Oncologia, Consiglio Nazionale delle Ricerche (CNR), Istituto Zooprofilattico Sperimentale Puglia e Basilicata, CIRCMSB – Cons. Int. Ricerca in Chimica dei Metalli nei Sistemi Biologici , Confindustria Puglia, Merck-Serono Spa, Sanofi-Aventis Spa, Centro di Competenza CERTA Scrl in liquidazione, Masmec Spa, ITEL Srl, StemGen Spa, Consorzio per Valutazioni Biologiche e Farmacologiche – CVBF- Italy, Cooperativa EDP La Traccia, Biotecgen Srl, Exprivia S.P.A.: AIS S.P.A., [email protected] S.P. A., Artificial Intelligence Software S.P.A., Daisy-Net Scarl, Gianni Benzi Onlus Pharmacological Research Foundation, Tecnopolis PST Scarl- Italy, NANOMED 3D Srl, Laboratorio dr. P. Pignatelli Srl- Italy, AB Analitica Srl, Sincon Srl, IMS Srl, Apulia Biotech Scr, Kos Genetic Srl.